Enzolytics Stock

Enzolytics P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Enzolytics (ENZC) as of Aug 15, 2026 is -58.56.

P/FCF

-58.56

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Enzolytics is 2026 -58.56 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Enzolytics was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Enzolytics Stock analysis

What does Enzolytics do? Enzolytics Inc is an innovative biotechnology company specializing in the development of effective therapies for combating infectious diseases and cancer. Enzolytics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzolytics stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Enzolytics is -58.56 in 2026.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Enzolytics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Enzolytics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Enzolytics

All Key Metrics — Enzolytics